Targeting STAT3 signaling using stabilised sulforaphane (SFX-01) inhibits endocrine resistant stem-like cells in ER-positive breast cancer

Estrogen receptor (ER) positive breast cancer is frequently sensitive to endocrine therapy. Multiple mechanisms of endocrine therapy resistance have been identified, including cancer stem-like cell (CSC) activity. Here we investigate SFX-01, a stabilised formulation of sulforaphane (SFN), for its ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Simões, Bruno M., Santiago-Gómez, Angélica, Chiodo, Chiara, Moreira, Tiago, Conole, Daniel, Lovell, Scott, Alferez, Denis, Eyre, Rachel, Spence, Katherine, Sarmiento-Castro, Aida, Kohler, Bertram, Morisset, Ludivine, Lanzino, Marilena, Andò, Sebastiano, Marangoni, Elisabetta, Sims, Andrew H., Tate, Edward W., Howell, Sacha J., Clarke, Robert B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299846/
https://www.ncbi.nlm.nih.gov/pubmed/32472077
http://dx.doi.org/10.1038/s41388-020-1335-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299846/
https://www.ncbi.nlm.nih.gov/pubmed/32472077
http://dx.doi.org/10.1038/s41388-020-1335-z

Ejemplares similares